Adenoviral vectors capable of replication improve the efficacy of HSVtk/GCV suicide gene therapy of cancer (original) (raw)
Moolten FL . Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: paradigm for a prospective cancer control strategy Cancer Res 1986 46: 5276–5281 CASPubMed Google Scholar
Freeman SM et al. The ‘bystander effect’: tumor regression when a fraction of the tumor mass is genetically modified Cancer Res 1993 53: 5274–5283 CASPubMed Google Scholar
Takamiya Y et al. Gene therapy of malignant brain tumors: a rat glioma line bearing the herpes simplex virus type 1-thymidine kinase gene and wild-type retrovirus kills other tumor cells J Neurosci Res 1992 33: 493–503 ArticleCASPubMed Google Scholar
Miyatake S, Martuza RL, Rabkin SD . Defective herpes simplex virus vectors expressing thymidine kinase for the treatment of malignant glioma Cancer Gene Ther 1997 4: 222–228 CASPubMed Google Scholar
Dion LD et al. E1A RNA transcripts amplify adenovirus-mediated tumor reduction Gene Therapy 1996 3: 1021–1025 CASPubMed Google Scholar
Culver KW et al. In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors Science 1992 256: 1550–1552 ArticleCASPubMed Google Scholar
Ram Z et al. Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells Nature Med 1997 3: 1354–1361 ArticleCASPubMed Google Scholar
Norrby E . Viral vaccines: the use of currently available products and future developments Arch Virol 1983 76: 163–177 ArticleCASPubMed Google Scholar
Smith RR et al. Studies on the use of viruses in the treatment of carcinoma of the cervix Cancer 1956 9: 1211–1218 ArticlePubMed Google Scholar
Southam CM . Present status of oncolytic virus studies Trans NY Acad Sci 1960 22: 657–673 ArticleCAS Google Scholar
Bischoff JR et al. An adenovirus mutant that replicates selectively in p53-deficient human tumor cells Science 1996 274: 373–376 ArticleCASPubMed Google Scholar
Freytag SO et al. A novel three-pronged approach to kill cancer cells selectively: concomitant viral, double suicide gene, and radiotherapy Hum Gene Ther 1998 9: 1323–1333 ArticleCASPubMed Google Scholar
Maxfield LF, Spector DJ . Readthrough activation of early adenovirus E1b gene transcription J Virol 1997 71: 8321–8329 CASPubMedPubMed Central Google Scholar
Larsson S, Svensson C, Akusjarvi G . Control of adenovirus major late gene expression at multiple levels J Mol Biol 1992 225: 287–298 ArticleCASPubMed Google Scholar
Thomas GP, Mathews MB . DNA replication and the early to late transition in adenovirus infection Cell 1980 22: 523–533 ArticleCASPubMed Google Scholar
Barker DD, Berk AJ . Adenovirus proteins from both E1B reading frames are required for transformation of rodent cells by viral infection and DNA transfection Virology 1987 156: 107–121 ArticleCASPubMed Google Scholar
Morgan RA et al. Retroviral vectors containing putative internal ribosome entry sites: development of a polycistronic gene transfer system and applications to human gene therapy Nucleic Acids Res 1992 20: 1293–1299 ArticleCASPubMedPubMed Central Google Scholar
van der Eb AJ, Mulder C, Graham FL, Houweling A . Transformation with specific fragments of adenovirus DNAs. I. Isolation of specific fragments with transforming activity of adenovirus 2 and 5 DNA Gene 1977 2: 115–132 ArticleCASPubMed Google Scholar
Berkner KL, Sharp PA . Effect of the tripartite leader on synthesis of a non-viral protein in an adenovirus 5 recombinant Nucleic Acids Res 1985 13: 841–857 ArticleCASPubMedPubMed Central Google Scholar
Mason BB et al. Adenovirus vaccine vectors expressing hepatitis B surface antigen: importance of regulatory elements in the adenovirus major late intron Virology 1990 177: 452–461 ArticleCASPubMed Google Scholar
Elshami AA et al. The effect of promoter strength in adenoviral vectors containing herpes simplex virus thymidine kinase on cancer gene therapy in vitro and in vivoCancer Gene Ther 1997 4: 213–221 CASPubMed Google Scholar
Eloit M, Adam M . Isogenic adenoviruses type 5 expressing or not expressing the E1A gene: efficiency as virus vectors in the vaccination of permissive and non-permissive species J Gen Virol 1995 76: 1583–1589 ArticleCASPubMed Google Scholar
Klein G, Klein E . Immune surveillance against virus-induced tumors and nonrejectability of spontaneous tumors: contrasting consequences of host versus tumor evolution Proc Natl Acad Sci USA 1977 74: 2121–2125 ArticleCASPubMedPubMed Central Google Scholar
Cook JL et al. Expression of the adenovirus E1A oncogene during cell transformation is sufficient to induce susceptibility to lysis by host inflammatory cells Proc Natl Acad Sci USA 1986 83: 6965–6969 ArticleCASPubMedPubMed Central Google Scholar
Bellgrau D, Walker TA, Cook JL . Recognition of adenovirus E1A gene products on immortalized cell surfaces by cytotoxic T lymphocytes J Virol 1988 62: 1513–1519 CASPubMedPubMed Central Google Scholar
Routes JM et al. Anti-adenovirus type 5 cytotoxic T lymphocytes: immunodominant epitopes are encoded by the E1A gene J Virol 1991 65: 1450–1457 CASPubMedPubMed Central Google Scholar
Cook JL, Potter TA, Bellgrau D, Routes BA . E1A oncogene expression in target cells induces cytolytic susceptibility at a post-recognition stage in the interaction with killer lymphocytes Oncogene 1996 13: 833–842 CASPubMed Google Scholar
Bonnekoh B et al. Adenoviral-mediated herpes simplex virus-thymidine kinase gene transfer in vivo for treatment of experimental human melanoma J Invest Dermatol 1996 106: 1163–1168 ArticleCASPubMed Google Scholar
Bett AJ, Haddara W, Prevec L, Graham FL . An efficient and flexible system for construction of adenovirus vectors with insertions or deletions in early regions 1 and 3 Proc Natl Acad Sci USA 1994 91: 8802–8806 ArticleCASPubMedPubMed Central Google Scholar
Graham FL, Prevec L . Methods for construction of adenovirus vectors Mol Biotechnol 1995 3: 207–220 ArticleCASPubMed Google Scholar
Kroumpouzos G, Eberle J, Garbe C, Orfanos CE . P53 mutation and c-fos overexpression are associated with detection of the antigen VLA-2 in human melanoma cell lines Pigment Cell Res 1994 7: 348–353 ArticleCASPubMed Google Scholar
Reuter S et al. Characterization of a novel human papillomavirus DNA in the cervical carcinoma cell line ME180 J Virol 1991 65: 5564–5568 CASPubMedPubMed Central Google Scholar
Dethlefsen LA, Prewitt JM, Mendelsohn ML . Analysis of tumor growth curves J Natl Cancer Inst 1968 40: 389–405 ArticleCASPubMed Google Scholar
Moolten FL, Wells JM . Curability of tumors bearing herpes thymidine kinase genes transferred by retroviral vectors J Natl Cancer Inst 1990 82: 297–300 ArticleCASPubMed Google Scholar
Ishii-Morita H et al. Mechanism of ‘bystander effect’ killing in the herpes simplex thymidine kinase gene therapy model of cancer treatment Gene Therapy 1997 4: 244–251 ArticleCASPubMed Google Scholar
Onodera M et al. A simple and reliable method for screening retroviral producer clones without selectable markers Hum Gene Ther 1997 8: 1189–1194 ArticleCASPubMed Google Scholar
Sambrook J, Fritsch EF, Maniatis T . Molecular Cloning: A Laboratory Manual, 2nd edn Cold Spring Harbor Laboratory Press: Plainview, NY 1989 Google Scholar
Feinberg AP, Vogelstein B . A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity Anal Biochem 1983 132: 6–13 ArticleCASPubMed Google Scholar
Agbaria R et al. Effects of IMP dehydrogenase inhibitors on the phosphorylation of ganciclovir in MOLT-4 cells before and after herpes simplex virus thymidine kinase gene transduction Mol Pharmacol 1994 45: 777–782 CASPubMed Google Scholar
Ahluwalia GS, Driscoll JS, Ford HJ, Johns DG . Comparison of the DNA incorporation in human MOLT-4 cells of two 2′-beta-fluoronucleosides, 2′-beta-fluoro-2′,3′-dideoxyadenosine and fialuridine J Pharm Sci 1996 85: 454–455 ArticleCASPubMed Google Scholar
Treisman J et al. Interleukin-2-transduced lymphocytes grow in an autocrine fashion and remain responsive to antigen Blood 1995 85: 139–145 CASPubMed Google Scholar